StockPriceToday
CDW Corp (CDW)
About CDW Corp
CDW Corporation provides comprehensive information technology solutions including hardware, software, and services to business, government, education, and healthcare customers across the United States, United Kingdom, and Canada. The company's role in IT procurement has made CDW stock price sensitive to enterprise technology spending and digital transformation trends.
CDW's solutions include laptops, servers, networking equipment, software licenses, cloud services, and security solutions that help organizations optimize their technology infrastructure. The company's services include consulting, implementation, and ongoing support for complex IT environments.
The company's specialized sales teams focus on specific customer segments and industry verticals to provide tailored solutions and expertise. CDW's partnerships with leading technology vendors enable competitive pricing and access to the latest products and services, influencing CDW stock price performance.
CDW's focus on customer relationships and technical expertise has enabled consistent growth and market share expansion. The company's ability to adapt to changing technology trends while maintaining customer loyalty remains important for its continued success in the competitive IT solutions market.
CDW Stock 12 Month Chart
Latest News for CDW
CDW Corporation has seen its share price move around over the past few years, and the real question now is whether the cash the business generates can justify where the stock trades today. With ...
CDW Corp. stock was last trading at USD 136.94 on Nasdaq on October 7, 2026, with a 52-week high of USD 161.10 and a 52-week low of USD 97.12. The next scheduled earnings date is November 4, 2026.
Shares of CDW Corp. CDW advanced 1.31% to $135.67 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.58% to 7,818.93 and the ...
Other Popular Stocks
Phathom Pharmaceuticals Inc. (PHAT) is a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, with a lead product targeting acid-related...
Y-mAbs Therapeutics Inc. (YMAB) is a commercial-stage biopharmaceutical company focused on developing and commercializing novel antibody-based therapies for the treatment of pediatric cancers.
Opera Limited (OPRA) is a technology company developing web browsers and digital content platforms with focus on mobile browsing, news aggregation, and advertising technology...